Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Special Report
  • Published:

Outcome of 5651 hematopoietic stem cell transplants for hematological malignancies carried out in Europe in 1993: a reliability study of the registry

Abstract

Outcome results of observational databases are frequently criticized as relying on incomplete information from incomplete patient populations. Few data are available to dispute these arguments of selection bias. The European Group for Blood and Marrow transplantation (EBMT) decided to address this question by evaluating the hematopoietic stem cell transplants performed in 1993. A comprehensive survey was launched in an effort to collect informations on all transplants for hematological malignancies performed throughout Europe during the year 1993. The main goals of this effort were to compare the group of spontaneously reported patients with the group of retrospectively solicited patients, and to give an accurate estimate of the outcome of all patients. For the year 1993, the annual EBMT activity survey indicated 6336 transplants performed for hematological malignancies in Europe. A total of 5651 transplants could be analyzed; 2595 were reported spontaneously by the teams (group A) and 3056 were retrieved on solicitation (group B). Patients and transplant characteristics for group A and B were very similar for most parameters with a few exceptions. There was no statistical difference for outcome at 3 years between groups A and B: disease-free survival (DFS) was 45 ± 1% and 44 ± 1%, relapse incidence (RI) 41 ± 1% and 42 ± 1%, transplant-related mortality (TRM) 23 ± 1% and 23 ± 1%, and overall survival (OS) 54 ± 1% and 55 ± 1%, respectively, for group A and group B. The real outcome at 3 years for the 5651 patients (group A + group B) transplanted in 1993 was 44 ± 1%, 41 ± 1%, 23 ± 1%, and 54 ± 1%, for DFS, RI, TRM and OS, respectively. The outcome at 3 years by transplant modality, autologous or allogeneic transplants, and by disease categories showed no difference between groups A and B.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Bortin MM, Rimm AA . Increasing utilization of bone marrow transplantation Transplantation 1986 42: 223 234

    Article  Google Scholar 

  2. Bortin MM, Rimm AA . Increasing utilization of bone marrow transplantation. Results of the 1985–1987 survey Transplantation 1989 48: 453 458

    Article  CAS  Google Scholar 

  3. Gratwohl A . Bone marrow transplantation activity in Europe 1990. Report from the European Group for Blood and Marrow transplantation Bone Marrow Transplant 1991 8: 197 201

    CAS  Google Scholar 

  4. Gratwohl A, Hermans J . Indications and donor source of hematopoietic stem cell transplants in Europe 1993 Clin Transplant 1995 9: 335 363

    Google Scholar 

  5. Gratwohl A, Hermans J, Baldomero H . Hematopoietic precursor cell transplants in Europe: activity in 1994. Report from the European Group for Blood and Marrow transplantation (EBMT) Bone Marrow Transplant 1996 17: 137 148

    CAS  Google Scholar 

  6. Gratwohl A, Passweg J, Baldomero H, Hermans J for the European Group for Blood and Marrow transplantation (EBMT). Blood and marrow transplantation activity in Europe 1996 Bone Marrow Transplant 1998 22: 227 240

    Article  CAS  Google Scholar 

  7. Gratwohl A, Passweg J, Baldomero H, Hermans J . Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow transplantation (EBMT) Bone Marrow Transplant 1999 24: 231 245

    Article  CAS  Google Scholar 

  8. Clift R, Goldman JM, Gratwohl A, Horowitz M . Proposals for standardized reporting of bone marrow transplantation for leukemia Bone Marrow Transplant 1989 4: 445 448

    CAS  PubMed  Google Scholar 

  9. Kaplan EL, Meier P . Non-parametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457 481

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported in part by EBMT funds, Association pour la Recherche contre le Cancer (ARC, Villejuif, France), Establissement Français des Greffes (EFG, Paris, France) and Associaton Claude Bernard (Paris, France).

Author information

Authors and Affiliations

Authors

Consortia

Appendix: Teams reporting data for this study

Appendix: Teams reporting data for this study

Dr Abdulkadirov, St Petersburg, Russia; Dr Abecasis, Lisboa, Portugal; Dr Abram, Belfast, Ireland (N); Dr Afanasiev, St Petersburg, Russia; Dr Aglietta, Torino, Italy; Dr Akoglu, Istanbul, Turkey; Dr Albrechtsen, Oslo, Norway; Dr Aldouri, Riyadh, Saudi Arabia; Dr Alessandrino, Pavia, Italy; Dr Amadori, Forli, Italy; Dr Amici, Perugia, Italy; Dr Andreesen, Regensburg, Germany; Dr Arnold, Berlin, Germany; Dr Attal, Toulouse, France; Dr Baccarani, Udine, Italy; Dr Bacigalupo, Genova, Italy; Dr Badell Serra, Barcelona, Spain; Dr Barbui, Bergamo, Italy; Dr Bartsch, Freiburg, Germany; Dr Baruchel, Paris, France; Dr Bauters, Lille Cedex, France; Dr Beguin, Liege, Belgium; Dr Bell, Poole, UK; Dr Ben-Bassat, Tel-Hashomer, Israel; Dr Berdel, Berlin, Germany; Dr Besalduch, Palma de Mallorca, Spain; Dr Biron, Lyon, France; Dr Björkholm, Stockholm, Sweden; Dr Blaise, Marseille, France; Dr Boasson, Angers, France; Dr Boesen, Arhus, Denmark; Dr Boguslawska-Jaworska, Wroclaw, Poland; Dr Boogaerts, Leuven, Belgium; Dr Bordignon, Milano, Italy; Dr Bosi, Firenze, Italy; Dr Broccia, Cagliari, Italy; Dr Brugger, Tübingen, Germany; Dr Büchner, Münster, Germany; Dr Burdach, Düsseldorf, Germany; Dr Burnett, Cardiff, UK; Dr Caballero, Salamanca, Spain; Dr Cacciola, Catania, Italy; Dr Cahn, Besancon, France; Dr Cajozzo, Palermo, Italy; Dr Campilho, Porto, Portugal; Dr Cao, Cagliari, Italy; Dr Carneskog, Goeteborg, Sweden; Dr Carrera Fernández, Oviedo, Spain; Dr Chapuis, Geneva, Switzerland; Dr Clark, Liverpool, UK; Dr Colombat, Tours Cedex, France; Dr Contreras, London, UK; Dr Contu, Cagliari, Italy; Dr Cornelissen, Rotterdam, Netherlands; Dr Cornish, Bristol, UK; Dr Coser, Bolzano, Italy; Dr Coze, Marseille, France; Dr Darbyshire, Birmingham, UK; Dr de Bock, Antwerp, Belgium; Dr De Cataldo, Milano, Italy; Dr De Laurenzi, Rome, Italy; Dr Deb, Rome, Italy; Dr Demeocq, Clermont-Ferrand, France; Dr Dennison, Vellore, India; Dr Devalck, Brussels, Belgium; Dr Diehl, Köln, Germany; Dr Dini, Genova, Italy; Dr Doelken, Greifswald, Germany; Dr Dörken, Berlin, Germany; Dr Efremidis, Athens, Greece; Dr Ehninger, Dresden, Germany; Dr Ernst, Riyadh, Saudi Arabia; Dr Errazquin, Sevilla, Spain; Dr Esquembre, Valencia, Spain; Dr Everaus, Tartu, Estonia; Dr Ezzat, Riyadh, Saudi Arabia; Dr Fassas, Exokhi, Greece; Dr Fasth, Goeteborg, Sweden; Dr Fauser, Idar-Oberstein, Germany; Dr Fekete, Budapest, Hungary; Dr Feremans, Brussels, Belgium; Dr Ferhanoglu, Istanbul, Turkey; Dr Fernández, Madrid, Spain; Dr Fernández-Ranada, Madrid, Spain; Dr Ferrant, Brussels, Belgium; Dr Filip, Hradec Králové, Czech Republic; Dr Finke, Freiburg, Germany; Dr Fischer, Paris, France; Dr Forjaz de Lacerda, Lisboa, Portugal; Dr Franklin, Glasgow, UK; Dr Freund, Rostock, Germany; Dr Friedrich, Ulm, Germany; Dr Fuchsberger, Bratislava, Slovakian Republic; Dr Gadner, Vienna, Austria; Dr Galvin, Wakefield, UK; Dr Garcia Lopez, Barcelona, Spain; Dr Garcia-Conde, Valencia, Spain; Dr Garcia-Larana, Madrid, Spain; Dr Gastearena, Pamplona, Spain; Dr Gastl, Innsbruck, Austria; Dr Gedikoglu, Istanbul, Turkey; Dr Ghavamzadeh, Teheran, Iran; Dr Gianni, Milano, Italy; Dr Gisselbrecht, Paris, France; Dr Gluckman, Paris, France; Dr Gmür, Zurich, Switzerland; Dr Goldman, London, UK; Dr Goldstone, London, UK; Dr Gorin, Paris, France; Dr Gramatzki, Erlangen, Germany; Dr Granena, Barcelona, Spain; Dr Granena, Barcelona, Spain; Dr Graphakos, Athens, Greece; Dr Gratecos, Nice, France; Dr Greco, Giovanni Rotondo, Italy; Dr Green, Woodville, Australia; Dr Greinix, Vienna, Austria; Dr Guéret-Wardle, London, UK; Dr Guilhot, Poitiers, France; Dr Guimaraes, Porto, Portugal; Dr Haas, Heidelberg, Germany; Dr Hamon, Plymouth, UK; Dr Hansen, Herlev, Denmark; Dr Hansz, Poznan, Poland; Dr Harhalakis, Athens, Greece; Dr Harousseau, Nantes, France; Dr Hart, Christchurch, New Zealand; Dr Hartmann, Villejuif, France; Dr Heit, Essen, Germany; Dr Hellmann, Gdansk, Poland; Dr Hermann, Ulm, Germany; Dr Herrmann, Perth, Australia; Dr Hertenstein, Hannover, Germany; Dr Hinterberger, Vienna, Austria; Dr Hoelzer, Frankfurt, Germany; Dr Holmes, Birmingham, UK; Dr Holowiecki, Katowice, Poland; Dr Huber, Mainz, Germany; Dr Hutchinson, Leicester, UK; Dr Iacopino, Reggio Calabria, Italy; Dr Iriondo, Santander, Spain; Dr Izzi, Brescia, Italy; Dr Jacobs, Wynberg, South Africa; Dr Jacobsen, Copenhagen, Denmark; Dr Jaksic, Zagreb, Croatia; Dr Joyner, Exeter, UK; Dr Juliá, Barcelona, Spain; Dr Juliusson, Linköping, Sweden; Dr Karianakis, Athens, Greece; Dr Katz, Montreal, Canada; Dr Kelemen, Budapest, Hungary; Dr Koc, Ankara, Turkey; Dr Kolb, München, Germany; Dr Konigorski, Wezembeek-Oppem, Belgium; Dr Kovacsovics, Lausanne, Switzerland; Dr Koza, Pilsen, Czech Republic; Dr Kubanek, Ulm, Germany; Dr Kvaloy, Oslo, Norway; Dr Labar, Zagreb, Croatia; Dr Lambertenghi Deliliers, Milano, Italy; Dr Lange, Wroclaw, Poland; Dr Lasa Isasti, San Sebastian, Spain; Dr Le Moine, Luxembourg, Luxembourg; Dr Leblond, Paris, France; Dr Legros, Clermont-Ferrand, France; Dr Lehtinen, Tampere, Finland; Dr Lelli, San Giovanni Rotondo, Italy; Dr Leone, Rome, Italy; Dr Leoni, Ancona, Italy; Dr Leyland, Birmingham, UK; Dr Leyvraz, Lausanne, Switzerland; Dr Linkesch, Graz, Austria; Dr Littlewood, Oxford, UK; Dr Ljungman, Huddinge, Sweden; Dr Locatelli, Pavia, Italy; Dr Löfvenberg, Umea, Sweden; Dr Lucarelli, Pesaro, Italy; Dr Lutz, Linz, Austria; Dr M. Michallet, Lyon, France; Dr Macchia, Pisa, Italy; Dr Madero, Madrid, Spain; Dr Madrigal, Hampstead London, UK; Dr Majolino, Palermo, Italy; Dr Maldonado Eloy-Garcia, Malaga, Spain; Dr Malesevic, Belgrade, Serbia; Dr Mandelli, Rome, Italy; Dr Marcus, Cambridge, UK; Dr Marsh, London, UK; Dr Martelli, Perugia, Italy; Dr Martin, Madrid, Spain; Dr Martinez-Rubio, Madrid, Spain; Dr McCann, Dublin, Ireland (Rep.); Dr McVerry, Leeds, UK; Dr Metzner, Oldenburg, Germany; Dr Milanovitch, Minsk, Belarus (Rep.); Dr Milovic, Buenos Aires, Argentinia; Dr Miniero, Torino, Italy; Dr Mistrik, Bratislava, Slovakian Republic; Dr Molina, Grenoble, France; Dr Montserrat, Barcelona, Spain; Dr Moraleda, Murcia, Spain; Dr Morell, Berne, Switzerland; Dr Morris, Belfast, Ireland (N); Dr Mufti, London, UK; Dr Myint, Bournemouth, UK; Dr Newland, London, UK; Dr Niederwieser, Innsbruck, Austria; Dr Niemeyer, Freiburg, Germany; Dr Niethammer, Tübingen, Germany; Dr Nilsson, Lund, Sweden; Dr Noens, Gent, Belgium; Dr Novitzky, Cape Town, South Africa; Dr O'Meara, Dublin, Ireland; Dr Ortega, Barcelona, Spain; Dr Ossenkoppele, Amsterdam, Netherlands; Dr Özerkan, Ankara, Turkey; Dr Papa, Rome, Italy; Dr Parker, Edinburgh, UK; Dr Parry, Gwynedd, UK; Dr Patrone, Genova, Italy; Dr Pavone, Bari, Italy; Dr Pedrazzoli, Pavia, Italy; Dr Pejin, Novi Sad, Yugoslavia; Dr Perona, Verona, Italy; Dr Pession, Bologna, Italy; Dr Pico, Villejuif, France; Dr Pintado Cros, Madrid, Spain; Dr Porcellini, Cremona, Italy; Dr Porta, Brescia, Italy; Dr Powles, Sutton, UK; Dr Pr H Ludwig, Vienna, Austria; Dr Prentice, Hampstead London, UK; Dr Pretnar, Ljubljana, Slovenia; Dr Proctor, Newcastle upon Tyne, UK; Dr Ptushkin, Moscow, Russia; Dr Reid, Harrow, UK; Dr Reiffers, Pessac, France; Dr Remes, Turku, Finland; Dr Richter, Mannheim, Germany; Dr Rio, Paris, France; Dr Rizzoli, Parma, Italy; Dr Robinson, Buenos Aires, Argentinia; Dr Rocha, Pamplona, Spain; Dr Rodeghiero, Vicenza, Italy; Dr Rodrìguez Fernández, Sevilla, Spain; Dr Rohatiner, London, UK; Dr Romeril, Wellington, New Zealand; Dr Rosenmayr, Vienna, Austria; Dr Rosti, Ravenna, Italy; Dr Rowe, Rochester, USA; Dr Russell, Calgary, Canada; Dr Russell, Nottingham, UK; Dr Ruutu, Helsinki, Finland; Dr Saarinen, Helsinki, Finland; Dr Salamon, Vienna, Austria; Dr Samson, London, UK; Dr Sante Tura, Bologna, Italy; Dr Sanz, Valencia, Spain; Dr Sayer, Jena, Germany; Dr Schaefer, Essen, Germany; Dr Schey, London, UK; Dr Schmitz, Kiel, Germany; Dr Schneider, Düsseldorf, Germany; Dr Schots, Brussels, Belgium; Dr Schouten, Maastricht, Netherlands; Dr Schroyens, Antwerp-Edegem, Belgium; Dr Schwarer, Melbourne, Australia; Dr Schwerdtfeger, Wiesbaden, Germany; Dr Seger, Zurich, Switzerland; Dr Selleslag, Brugge, Belgium; Dr Shaw, Sydney, Australia; Dr Siegert, Berlin, Germany; Dr Singer, Bath, UK; Dr Sirchia, Milano, Italy; Dr Slavin, Jerusalem, Israel; Dr Souillet, Lyon, France; Dr Speck, Basel, Switzerland; Dr Spence, Clydebank, UK; Dr Stephan, Saint Etienne, France; Dr Stryckmans, Brussels, Belgium; Dr Sulek, Warszawa, Poland; Dr Sweetenham, Southampton, UK; Dr Tangün, Istanbul, Turkey; Dr Tanyeli, Balcali/Adana, Turkey; Dr Tidefelt, Örebro, Sweden; Dr Tobler, Bern, Switzerland; Dr Torelli, Modena, Italy; Dr Torlontano, Pescara, Italy; Dr Torres Gomez, Cordoba, Spain; Dr Tötterman, Uppsala, Sweden; Dr Touraine, Lyon, France; Dr Treuner, Stuttgart, Germany; Dr Trneny, Praha 2, Czech Republic; Dr Troussard, Caen, France; Dr Trümper, Homburg/Saar, Germany; Dr Uderzo, Monza, Italy; Dr Urban, Graz, Austria; Dr Van den Berg, Amsterdam, Netherlands; Dr Van Marwijk, GK Zwolle, Netherlands; Dr Vandenberghe, Sheffield, UK; Dr Vellenga, Groningen, Netherlands; Dr Verdonck, Utrecht, Netherlands; Dr Vernant, Creteil, France; Dr Veys, London, UK; Dr Vitek, Praha, Czech Republic; Dr Volpe, Avellino, Italy; Dr Vorlìcek, Brno, Czech Republic; Dr Vossen, Leiden, Netherlands; Dr Wachowiak, Poznan, Poland; Dr Walewski, Warszawa, Poland; Dr Wandt, Nürnberg, Germany; Dr Wernli, Aarau, Switzerland; Dr Westerhausen, Duisburg, Germany; Dr Wijermans Hague, Netherlands; Dr Will, Pendlebury, UK; Dr Witte, Nijmegen, Netherlands; Dr Wolf, Marburg, Germany; Dr Yaniv, Petach-Tikva, Israel; Dr Zander, Hamburg, Germany; Dr Zegers, Utrecht, Netherlands; Dr Zintl, Jena, Germany; Dr Zucker, Paris, France.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fouillard, L., Labopin, M., Gratwohl, A. et al. Outcome of 5651 hematopoietic stem cell transplants for hematological malignancies carried out in Europe in 1993: a reliability study of the registry. Bone Marrow Transplant 30, 637–643 (2002). https://doi.org/10.1038/sj.bmt.1703712

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703712

Keywords

Search

Quick links